Albemarle Corp buy UBS Group AG
Start price
12.01.26
/
50%
€143.84
Target price
12.01.27
-
Performance (%)
-19.84%
Price
08:48
€115.30
Summary
This prediction is currently active. The prediction for Albemarle Corp disappoints with a performance of -19.84%. This prediction currently runs until 12.01.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionAlbemarle is a specialty chemical company that produces and markets lithium, bromine, and other specialty chemicals globally. The company's products are used in a wide range of applications, including energy storage, flame retardants, pharmaceuticals, and agricultural solutions. Albemarle's lithium business has been a key driver of growth in recent years due to increasing demand for lithium-ion batteries used in electric vehicles and other technologies. The company has a market capitalization of around $11 billion and is listed on the New York Stock Exchange under the ticker symbol ALB.
AI-generated
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Albemarle Corp | 1.714% | 1.714% |
| iShares Core DAX® | -0.046% | 5.960% |
| iShares Nasdaq 100 | 0.922% | 3.693% |
| iShares Nikkei 225® | 3.014% | 6.638% |
| iShares S&P 500 | -0.359% | 2.747% |
Comments by UBS_Group_AG for this prediction
In the thread Albemarle Corp diskutieren
Albemarle (NYSE:ALB) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Ratings data for ALB provided by MarketBeat
Stopped prediction by UBS_Group_AG for Albemarle Corp
Albemarle Corp
Start price
Target price
Perf. (%)
€196.80
18.05.23
18.05.23
€208.46
18.05.24
18.05.24
-38.27%
19.05.24
19.05.24
